Literature DB >> 2346735

Anti-erythropoietin antibodies in hyperviscosity syndrome associated with giant lymph node hyperplasia (GLNH; Castleman's disease).

J J Steinberg1, P L Huang, P Ljubich, S Lee-Huang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2346735     DOI： 10.1111/j.1365-2141.1990.tb06351.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Bilateral neovascular glaucoma due to multicentric Castleman disease.

Authors:  Takayasu Omata; Teruhiko Hamanaka; Soichiro Ikushima; Masaru Oritsu
Journal:  Jpn J Ophthalmol       Date:  2008-03-28       Impact factor: 2.447

2.  Neutralizing interferon beta antibodies in melanoma patients treated with recombinant and natural interferon beta.

Authors:  G Fierlbeck; T Schreiner; B Schaber; A Walser; G Rassner
Journal:  Cancer Immunol Immunother       Date:  1994-10       Impact factor: 6.968

3.  Increased interleukin-6 (IL-6) production in a young child with clinical and pathologic features of multicentric Castleman's disease.

Authors:  M C Kinney; D S Hummell; P M Villiger; A Hourigan; L Rollins-Smith; A D Glick; A R Lawton
Journal:  J Clin Immunol       Date:  1994-11       Impact factor: 8.317

4.  Intestinal lymphangiectasia associated with angiofollicular lymph node hyperplasia (Castleman's disease).

Authors:  S F Moss; D M Thomas; C Mulnier; I G McGill; H J Hodgson
Journal:  Gut       Date:  1992-01       Impact factor: 23.059
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.